Altimetrik’s Rajesh Ananth Wins 2022 Excellence in Customer Service Award
DETROIT–(BUSINESS WIRE)–Altimetrik, a leading digital business enablement company, today announced that Rajesh Ananth has been…
News
Equideum Health Appoints Oki Mek as Chief Information Security Officer to Ensure Robust Security of its Critical Infrastructure and Implementation of Trusted AI Models
Mek will bring unique HHS cybersecurity, AI and blockchain experience to Equideum Health He will…
New White Paper Lays Out Methods for Financial Institutions to Make the Most of Trading Flow Data
LeapYear study focuses on areas where trading desks can create competitive differentiation SAN FRANCISCO–(BUSINESS WIRE)–Now…
Ceapro Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
– FY 2021 record sales of $17,200,000 compared to $15,100,000 for FY 2020, representing a…
Allogene Therapeutics Publishes Preclinical Data on ALLO-316, an AlloCAR T™ Candidate Targeting CD70 for the Treatment of Renal Cell Carcinoma, at AACR’s Annual Meeting and in Cancer Research Journal
Data Continue to Highlight the Potential of ALLO-316 to Treat Both Solid Tumors and Hematologic…
TransCode Therapeutics’ CTO, Dr. Zdravka Medarova, to Moderate 7th Annual RNA Medicine Symposium
Dr. Medarova will present at the 3rd Annual RNAi-Based Therapeutics Summit on April 20 BOSTON,…
Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia
New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13 SOLANA BEACH, Calif.,…
Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2…
Nuvectis Pharma Recaps Poster Presentation Highlights for NXP900 at the 2022 American Association for Cancer Research (AACR) Conference
Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis”…
IN8bio Continues to Build on its Clinical and Regulatory Team with Two Key Appointments
Urvashi Patel, Ph.D., as Vice President, Regulatory Affairs Stacey Bilinski, as Vice President, Clinical Operations…
Oncternal Therapeutics Deprioritizes Development of ONCT-216 to Focus Resources on Phase 3 Trial for Zilovertamab in the Treatment of Mantle Cell Lymphoma
Discontinued enrollment of Phase 1/2 trial of ONCT-216 in Ewing sarcoma Resources will be primarily…
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company…
First Cigarette That “Helps You Smoke Less” Launches National Pilot in Chicagoland
VLN® Reduced Nicotine Content Cigarettes Launch in Chicagoland Pilot VLN® 95% reduced nicotine content cigarettes…
Renibus Therapeutics Strengthens IP Position with Additional US Patent
Renibus Therapeutics granted patent approval for the novel aqueous iron composition of RBT-3, a product…
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
Second U.S. orphan drug designation for efzofitimod clinical program SAN DIEGO, April 13, 2022 (GLOBE…
Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to $40 Million with Lincoln Park Capital
Provides Access to Additional Capital to Support Growth WARREN, N.J., April 13, 2022 (GLOBE NEWSWIRE)…
Applied Molecular Transport Announces Publication in Tissue Barriers Providing Additional Insight into Company’s Proprietary Technology Platform
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by…
Recce Pharmaceuticals Announces Phase I Clinical Trial of RECCE® 327 Advances to High Dosing Level
Dose increase of R327 Dose increase of R327 Highlights: 36 subjects successfully dosed in Phase…
Praxis Precision Medicines to Host Epilepsy Day on April 27, 2022
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Baudax Bio to Present at NobleCon18 Investor Conference
MALVERN, Pa., April 13, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…